Literature DB >> 6448917

CFS hydroxylase cofactor levels in some neurological diseases.

A C Williams, R A Levine, T N Chase, W Lovenberg, D B Calne.   

Abstract

The cerebrospinal fluid concentration of hydroxylase cofactor has been measured in patients with Parkinson's disease, the Shy-Drager and Steele-Richardson syndromes, adult onset focal dystonia, essential tremor, Huntington's disease and presenile dementia. The results were compared with age matched controls and low values were demonstrated for all disease groups studied except for focal dystonia.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6448917      PMCID： PMC490647          DOI： 10.1136/jnnp.43.8.735

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  17 in total

1.  Phenylketonuria due to a deficiency of dihydropteridine reductase.

Authors:  S Kaufman; N A Holtzman; S Milstien; L J Butler; A Krumholz
Journal:  N Engl J Med       Date:  1975-10-16       Impact factor: 91.245

2.  Action tremor and the cogwheel phenomenon in Parkinson's disease.

Authors:  J W LANCE; R S SCHWAB; E A PETERSON
Journal:  Brain       Date:  1963-03       Impact factor: 13.501

3.  In vivo enhancement of tyrosine hydroxylation in rat striatum by tetrahydrobiopterin.

Authors:  R Kettler; G Bartholini; A Pletscher
Journal:  Nature       Date:  1974-05-31       Impact factor: 49.962

4.  Biochemical and pharmacologic studies of dystonia.

Authors:  T N Chase
Journal:  Neurology       Date:  1970-11       Impact factor: 9.910

5.  Preliminary remarks on the L-dopa therapy of dystonia.

Authors:  M Coleman
Journal:  Neurology       Date:  1970-11       Impact factor: 9.910

6.  Selective loss of central cholinergic neurons in Alzheimer's disease.

Authors:  P Davies; A J Maloney
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

7.  Regional and subcellular distribution and some factors in the regulation of reduced pterins in rat brain.

Authors:  W P Bullard; P B Guthrie; P V Russo; A J Mandell
Journal:  J Pharmacol Exp Ther       Date:  1978-07       Impact factor: 4.030

8.  Dialysis dementia, aluminium, and tetrahydrobiopterin metabolism.

Authors:  R J Leeming; J A Blair
Journal:  Lancet       Date:  1979-03-10       Impact factor: 79.321

9.  Hyperphenylalaninemia due to a deficiency of biopterin. A variant form of phenylketonuria.

Authors:  S Kaufman; S Berlow; G K Summer; S Milstien; J D Schulman; S Orloff; S Spielberg; S Pueschel
Journal:  N Engl J Med       Date:  1978-09-28       Impact factor: 91.245

10.  Diminished ventricular fluid dopamine metabolites in adult-onset dystonia.

Authors:  K Tabaddor; L I Wolfson; N S Sharpless
Journal:  Neurology       Date:  1978-12       Impact factor: 9.910
View more
  17 in total

1.  Isolation of a full-length cDNA clone for human GTP cyclohydrolase I type 1 from pheochromocytoma.

Authors:  T Nomura; M Ohtsuki; S Matsui; C Sumi-Ichinose; H Nomura; Y Hagino; K Iwase; H Ichinose; K Fujita; T Nagatsu
Journal:  J Neural Transm Gen Sect       Date:  1995

2.  Visual evoked potentials and neopterin: biopterin ratios in urine show a high correlation in Alzheimer's disease.

Authors:  C G Hamon; R J Cattell; C E Wright; O Wychrij; J A Blair; G F Harding
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-02       Impact factor: 10.154

3.  Metabolomic Responses to Manganese Dose in SH-SY5Y Human Neuroblastoma Cells.

Authors:  Jolyn Fernandes; Joshua D Chandler; Ken H Liu; Karan Uppal; Li Hao; Xin Hu; Young-Mi Go; Dean P Jones
Journal:  Toxicol Sci       Date:  2019-05-01       Impact factor: 4.849

4.  Tetrahydrobiopterin metabolism in senile dementia of Alzheimer type.

Authors:  A A Aziz; R J Leeming; J A Blair
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-05       Impact factor: 10.154

Review 5.  Tetrahydrobiopterin availability in Parkinson's and Alzheimer's disease; potential pathogenic mechanisms.

Authors:  Richard H Foxton; John M Land; Simon J R Heales
Journal:  Neurochem Res       Date:  2006-12-27       Impact factor: 3.996

6.  Tetrahydrobiopterin metabolism in senile dementia of Alzheimer type.

Authors:  C Morar; S B Whitburn; J A Blair; R J Leeming; G K Wilcock
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-06       Impact factor: 10.154

7.  Meningitis and disseminated cutaneous zoster complicating herpes zoster infection.

Authors:  S J Karp
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-06       Impact factor: 10.154

8.  Biosynthesis of tetrahydrobiopterin by de novo and salvage pathways in adrenal medulla extracts, mammalian cell cultures, and rat brain in vivo.

Authors:  C A Nichol; C L Lee; M P Edelstein; J Y Chao; D S Duch
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

9.  Immunocytochemical localization of GTP cyclohydrolase I in the brain, adrenal gland, and liver of mice.

Authors:  I Nagatsu; H Ichinose; M Sakai; K Titani; M Suzuki; T Nagatsu
Journal:  J Neural Transm Gen Sect       Date:  1995

10.  Differences in the metabolism of the aromatic amino acid hydroxylase cofactor, tetrahydrobiopterin, in mutant mice with neurological and immunological defects.

Authors:  D S Duch; S W Bowers; J H Woolf; M T Davisson; L J Maltais; C A Nichol
Journal:  Biochem Genet       Date:  1986-10       Impact factor: 1.890
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.